VKTX - Viking Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.67
DETAILS
HIGH:
$101.00
LOW:
$95.00
MEDIAN:
$100.00
CONSENSUS:
$98.67
UPSIDE:
222.87%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.4 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.4) | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 345.0 | 101.6 | 63.8 | 54.2 | 45.0 | 31.9 | 23.6 | 19.0 | 13.7 | 9.0 | 7.0 | 22.2 | 0.0 | 0.0 |
| SG&A Expenses | 48.4 | 49.3 | 37.0 | 16.1 | 10.7 | 10.7 | 8.9 | 7.1 | 5.3 | 4.8 | 5.0 | 1.2 | 0.1 | 0.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 393.3 | 150.9 | 100.8 | 70.4 | 55.7 | 42.7 | 32.4 | 26.2 | 19.1 | 13.8 | 12.0 | 23.5 | 0.1 | 0.0 |
| Operating Income | ||||||||||||||
| Operating Income | (393.3) | (150.9) | (100.8) | (70.4) | (55.7) | (42.7) | (32.7) | (26.2) | (19.1) | (13.8) | (12.0) | (23.5) | (0.1) | (0.0) |
| Interest Expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.6 | 2.0 | 2.0 | 1.0 | 0.6 | 0.0 | 0 |
| Interest Income | 33.7 | 40.9 | 15.0 | 1.6 | 0.7 | 3.2 | 7.0 | 3.3 | 0.1 | 0.1 | 0.0 | 0 | 0 | 0.0 |
| Profitability | ||||||||||||||
| EBITDA | (393.3) | (150.6) | (100.5) | (70.1) | (55.4) | (39.1) | (25.4) | 4.7 | 0.4 | 1.1 | (22.4) | (21.3) | (0.1) | (0.1) |
| EBIT | (393.3) | (150.9) | (100.8) | (70.4) | (55.7) | (39.4) | (25.6) | (21.5) | (18.6) | (12.7) | (22.4) | (23.5) | (0.1) | (0.1) |
| Income Before Tax | (359.6) | (110.0) | (85.9) | (68.9) | (55.0) | (39.5) | (25.8) | (22.1) | (20.6) | (14.7) | (23.4) | (21.9) | (0.1) | (0.0) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Net Income | (359.6) | (110.0) | (85.9) | (68.9) | (55.0) | (39.5) | (25.8) | (22.1) | (20.6) | (14.7) | (23.4) | (21.9) | (0.1) | (0.0) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -3.19 | -1.01 | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 | -0.79 | -0.90 | -3.68 | -5.08 | -0.03 | -0.30 |
| EPS (Diluted) | -3.19 | -1.01 | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 | -0.79 | -0.90 | -3.68 | -5.08 | -0.03 | -0.30 |
| Shares Outstanding | 112.7 | 109.0 | 94.3 | 76.8 | 77.2 | 72.6 | 72.0 | 57.6 | 26.0 | 16.3 | 6.4 | 4.3 | 4.3 | 0.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 165.8 | 26.7 | 55.5 | 36.6 | 26.4 | 29.1 | 8.4 | 24.8 | 9.0 | 3.1 |
| Short-Term Investments | 539.9 | 875.9 | 306.6 | 118.9 | 175.7 | 219.3 | 267.3 | 276.7 | 11.6 | 10.1 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 9.9 | 1.1 | 2.5 | 8.1 | 7.8 | 7.3 | 7.5 | 0 | 0.4 | 0.8 |
| Total Current Assets | 715.6 | 907.2 | 367.2 | 167.0 | 210.5 | 256.1 | 283.5 | 302.1 | 21.9 | 14.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 0.1 | 1.0 | 1.1 | 1.4 | 0.0 | 0.3 | 0.6 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.6 |
| Total Non-Current Assets | 0.1 | 1.1 | 1.3 | 1.5 | 0.1 | 0.4 | 0.8 | 0.2 | 0.3 | 0.6 |
| Total Assets | 715.7 | 908.3 | 368.5 | 168.5 | 210.7 | 256.5 | 284.3 | 302.3 | 22.1 | 14.5 |
| Current Liabilities | ||||||||||
| Account Payables | 53.3 | 9.8 | 7.5 | 8.5 | 1.4 | 4.0 | 2.4 | 1.0 | 1.5 | 1.2 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.5 | 3.3 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.3 | 1.3 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.4 | 0.7 |
| Total Current Liabilities | 76.7 | 27.4 | 19.1 | 21.9 | 8.8 | 12.1 | 6.8 | 4.5 | 8.7 | 6.5 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 |
| Total Non-Current Liabilities | 0 | 0.6 | 0.9 | 1.3 | 0 | 0.0 | 0.4 | 0.0 | 5.0 | 0.0 |
| Total Liabilities | 76.7 | 28.0 | 20.1 | 23.2 | 8.8 | 12.2 | 7.1 | 4.6 | 8.7 | 6.5 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (847.5) | (487.9) | (377.9) | (292.0) | (223.2) | (168.2) | (128.7) | (102.9) | (80.9) | (60.3) |
| Accumulated Other Comprehensive Income | 0.4 | (0.8) | (0.4) | (1.1) | (0.5) | (0.1) | 0.0 | (0.4) | (0.0) | (0.0) |
| Total Stockholders' Equity | 639.1 | 880.3 | 348.4 | 145.3 | 201.9 | 244.3 | 277.1 | 297.8 | 13.5 | 8.0 |
| Total Liabilities & Equity | 715.7 | 908.3 | 368.5 | 168.5 | 210.7 | 256.5 | 284.3 | 302.3 | 22.1 | 14.5 |
| Debt Metrics | ||||||||||
| Total Debt | 0.1 | 1.1 | 1.3 | 1.6 | 0.0 | 0.4 | 0.7 | 0 | 3.5 | 3.3 |
| Net Debt | (165.7) | (25.6) | (54.3) | (35.1) | (26.3) | (28.8) | (7.7) | (24.8) | (5.5) | 0.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (359.6) | (110.0) | (85.9) | (68.9) | (55.0) | (39.5) | (25.8) | (22.1) | (20.6) | (14.7) |
| Depreciation & Amortization | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 1.4 | 1.9 |
| Stock-Based Compensation | 40.8 | 29.7 | 16.8 | 8.7 | 6.1 | 5.8 | 3.7 | 2.6 | 1.5 | 1.8 |
| Change in Working Capital | 49.0 | 9.4 | 3.5 | 10.2 | (2.9) | 7.7 | (3.8) | 0.8 | 1.8 | 0.8 |
| Other Non-Cash Items | (9.3) | (17.2) | (8.1) | 1.3 | 3.9 | 3.9 | 0.8 | (0.2) | 2.5 | 0.9 |
| Operating Cash Flow | (278.7) | (87.8) | (73.4) | (48.4) | (47.6) | (21.8) | (24.8) | (18.8) | (14.8) | (11.1) |
| Investing Activities | ||||||||||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (418.0) | (1,113.4) | (478.3) | (121.4) | (168.0) | (280.6) | (362.4) | (348.2) | (22.5) | (16.9) |
| Sales/Maturities of Investments | 759.4 | 560.0 | 299.2 | 176.2 | 206.0 | 322.2 | 369.9 | 82.5 | 20.8 | 20.0 |
| Other Investing Activities | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | (0.3) | (0.0) | 0.0 |
| Investing Cash Flow | 341.4 | (553.4) | (179.1) | 54.8 | 38.0 | 41.6 | 7.5 | (265.7) | (1.7) | 3.0 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (3.8) | (0.1) | (0.1) |
| Stock Repurchased | 0 | 0 | 0 | (6.8) | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 73.9 | 15.4 | 1.6 | 12.5 | (0.7) | (0.3) | (0.2) | 7.5 | 0.1 | (1.1) |
| Financing Cash Flow | 76.4 | 612.5 | 271.4 | 4.2 | 6.9 | 0.9 | 0.9 | 300.3 | 22.4 | 10.3 |
| Cash Position | ||||||||||
| Net Change in Cash | 139.1 | (28.8) | 18.9 | 10.3 | (2.7) | 20.7 | (16.4) | 15.8 | 5.9 | 2.3 |
| Cash at Beginning | 26.7 | 55.5 | 36.6 | 26.4 | 29.1 | 8.4 | 24.8 | 9.0 | 3.1 | 0.8 |
| Cash at End | 165.8 | 26.7 | 55.5 | 36.6 | 26.4 | 29.1 | 8.4 | 24.8 | 9.0 | 3.1 |
| Free Cash Flow | (278.7) | (87.8) | (73.4) | (48.4) | (47.6) | (21.8) | (24.8) | (18.8) | (14.8) | (11.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.4) | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (393.3) | (150.9) | (100.8) | (70.4) | (55.7) | (42.7) | (32.7) | (26.2) | (19.1) | (13.8) | (12.0) | (23.5) | (0.1) | (0.0) |
| Net Income | (359.6) | (110.0) | (85.9) | (68.9) | (55.0) | (39.5) | (25.8) | (22.1) | (20.6) | (14.7) | (23.4) | (21.9) | (0.1) | (0.0) |
| EPS (Diluted) | -3.19 | -1.01 | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 | -0.79 | -0.90 | -3.68 | -5.08 | -0.03 | -0.30 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 165.8 | 26.7 | 55.5 | 36.6 | 26.4 | 29.1 | 8.4 | 24.8 | 9.0 | 3.1 | ||||
| Total Assets | 715.7 | 908.3 | 368.5 | 168.5 | 210.7 | 256.5 | 284.3 | 302.3 | 22.1 | 14.5 | ||||
| Total Debt | 0.1 | 1.1 | 1.3 | 1.6 | 0.0 | 0.4 | 0.7 | 0 | 3.5 | 3.3 | ||||
| Stockholders' Equity | 639.1 | 880.3 | 348.4 | 145.3 | 201.9 | 244.3 | 277.1 | 297.8 | 13.5 | 8.0 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (278.7) | (87.8) | (73.4) | (48.4) | (47.6) | (21.8) | (24.8) | (18.8) | (14.8) | (11.1) | ||||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Free Cash Flow | (278.7) | (87.8) | (73.4) | (48.4) | (47.6) | (21.8) | (24.8) | (18.8) | (14.8) | (11.1) | ||||